Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  CANADIAN NATIONAL STOCK EXCHANGE  >  Cresco Labs Inc.    CL   CA22587M1068


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Cresco Labs : Announces Upcoming Conference Participation

11/19/2020 | 08:02am EST

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following conferences:

  • Cowen’s 2020 Boston Cannabis Conference – November 30th, 2020 – Management will participate in virtual one-on-one meetings. Charlie Bachtell, CEO and Co-Founder, will participate on the “U.S. MSOs: The Mid-West” panel. Barrington Rutherford, SVP of Real Estate & Community Integration, will participate on the “inclusion & Diversity” panel.
  • Roth Virtual Deer Valley Consumer Event – December 9th-11th, 2020 – Management will participate in virtual one-on-one meetings and Charlie Bachtell, CEO and Co-Founder, will participate on a panel.
  • 2020 Cantor Fitzgerald Virtual Cannabis MSO Summit – December 15th-16th, 2020 – Charlie Bachtell, CEO and Co-Founder, will participate in a fireside chat. Register here.

About Cresco Labs

Cresco Labs is one of the largest vertically-integrated multi-state cannabis operators in the United States. Cresco is built to become the most important company in the cannabis industry by combining the most strategic geographic footprint with one of the leading distribution platforms in North America. Employing a consumer-packaged goods (“CPG”) approach to cannabis, Cresco’s house of brands is designed to meet the needs of all consumer segments and includes some of the most recognized and trusted national brands including Cresco, Remedi, High Supply, Reserve, Good News and Mindy’s Chef Led Artisanal Edibles created by James Beard Award-winning chef Mindy Segal. Sunnyside, Cresco’s national dispensary brand, is a wellness-focused retailer designed to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco provides the industry’s first national comprehensive Social Equity and Educational Development (SEED) program designed to ensure that all members of society have the skills, knowledge and opportunity to work in and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com.

Forward Looking Statements

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under "Risk Factors" in the company’s CSE Listing Statement filed with SEDAR; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco’s shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.

© Business Wire 2020
All news about CRESCO LABS INC.
01/19Cresco Labs Close To 52-Week Highs After Hiring PepsiCo Veteran Ty Gent As Ch..
01/19CRESCO LABS : Hires PepsiCo Veteran and Supply Chain Expert Ty Gent as Its New C..
01/18Haywood Capital Markets Raises Cresco Labs PT To $24 From $20
01/18CRESCO LABS : Employees Volunteer Over 5,000 Hours for Company's 2020 “Mak..
01/15Cresco Labs Up More Than 6% As Prices Offering of Subordinate Voting Shares
01/15CRESCO LABS :  Cresco Labs Announces Pricing of Offering of Subordinate Voting S..
01/14CRESCO LABS : Announces Proposed Offering of Subordinate Voting Shares
01/14CRESCO LABS : Bluma Transaction Presentation
01/14CRESCO LABS BRIEF : Expanding Into Florida Through Acquisition of Fellow CSE-lis..
01/14CRESCO LABS : to Expand Into Florida Through Acquisition of Bluma Wellness Inc.
More news
Financials (USD)
Sales 2020 476 M - -
Net income 2020 -18,2 M - -
Net Debt 2020 133 M - -
P/E ratio 2020 -170x
Yield 2020 -
Capitalization 3 278 M 3 276 M -
EV / Sales 2020 7,16x
EV / Sales 2021 4,06x
Nbr of Employees 2 000
Free-Float 50,0%
Duration : Period :
Cresco Labs Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CRESCO LABS INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 14
Average target price 19,88 CAD
Last Close Price 17,59 CAD
Spread / Highest target 36,4%
Spread / Average Target 13,0%
Spread / Lowest Target -20,4%
EPS Revisions
Managers and Directors
Charles Bachtell Chief Executive Officer & Director
Thomas Joseph Manning Executive Chairman
David Ellis Chief Operating Officer
Dennis M. Olis Chief Financial Officer
Mo Dastagir Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
CRESCO LABS INC.40.16%3 276
JOHNSON & JOHNSON3.18%427 472
ROCHE HOLDING AG3.56%308 129
NOVARTIS AG2.82%219 666
MERCK & CO., INC.0.81%208 627
PFIZER INC.-0.84%202 881